| Literature DB >> 28822192 |
Xiao-Dan Zhang1, Shu-Ya Zhao1, Yun-Lin Li1, Da-Ling Zhu2, Ru Zhang1, Jie-Jing Sheng1, Shu-Jing Wang1.
Abstract
To investigate the effect of taurine(Tau) on ICAM-1, VCAM-1 by p-p38 pathway in bovine pulmonary artery endothelial cells(PAECs) and explore its mechanism of action. Generation 4-12 cells in primary cultures of PAECs were used in experiments and divided into five groups: control group, hypoxia(hyp) group, inhibitor(SB203580) group, treatment(Tau) group, and treatment+inhibitor(SB+Tau) group. The concentration of Tau:100 mmol•L⁻¹; p38 inhibitor SB203580: 20 μmol•L⁻¹; and the treatment time was 12 h. MTT assay was used to detect the inhibitory effect of different concentrations of Tau on PAECs. Western blot and Real-time PCR method were used to detect the p38 pathway proteins and ICAM-1, VCAM-1 expression levels. Immunofluorescence was used to investigate p38 nuclear displacement situation. The results of MTT showed that the inhibitory effect was gradually increased with increasing concentrations of Tau. Western blot and RT-PCR revealed that the protein and mRNA expression levels of ICAM-1, VCAM-1 were reduced by Tau. Western blot and immunofluorescence showed Tau can inhibit p38 activation. Tau may decrease the expression levels of VCAM-1 and ICAM-1 in endothelial cells induced by hypoxia through MAPK p38 pathway. Copyright© by the Chinese Pharmaceutical Association.Entities:
Keywords: ICAM-1; VCAM-1; p38 pathway; taurine
Mesh:
Substances:
Year: 2017 PMID: 28822192 DOI: 10.19540/j.cnki.cjcmm.2017.0112
Source DB: PubMed Journal: Zhongguo Zhong Yao Za Zhi ISSN: 1001-5302